Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - IRIS BIOTECHNOLOGIES INC | irsb022413form8k.htm |
EXHIBIT 16.1
RBSM LLP
New York, New York
February 26, 2013
Securities and Exchange Commission
100 F Street, N.W.
Washington, DC 20549-7561
Dear Sirs/Madams:
We have read Item 4.01 of Iris Biotechnologies, Inc. (the “Company”) Form 8-K dated February 21, 2013, and are in agreement with the statements relating only to RBSM LLP contained therein. We have no basis to agree or disagree with other statements of the Company contained therein
Very truly yours,
s/s RBSM LLP